Aislamientos clínicos colombianos de Cryptococcus neoformans y Cryptococcus gattii desarrollan heterorresistencia a fluconazol en altas concentraciones de este triazol

Translated title of the contribution: Colombian clinical isolates of Cryptococcus neoformans and Cryptococcus gattii develop heteroresistance to fluconazole at high concentrations of this triazole.

Research output: Knowledge networksAbstractpeer-review

Translated title of the contributionColombian clinical isolates of Cryptococcus neoformans and Cryptococcus gattii develop heteroresistance to fluconazole at high concentrations of this triazole.
Original languageSpanish (Colombia)
StateSubmitted - Nov 25 2021
EventXVII Encuentro Científico - Instituto Nacional de Salud - Virtual, Bogotá, Colombia
Duration: Nov 24 2021Nov 26 2021

Conference

ConferenceXVII Encuentro Científico - Instituto Nacional de Salud
Country/TerritoryColombia
CityBogotá
Period11/24/2111/26/21

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)

Cite this